Karen Burke, PhD
Regulatory
Dr. Karen Burke was most recently Director of Regulatory Affairs, Drug Safety and Quality Assurance at Amgen Canada, and prior to that, Vice President, Regulatory Affairs at AstraZeneca Canada. She served as President of the 4,000-member Canadian Society for Chemistry during the International Year of Chemistry in 2010-2011. Dr. Burke was an active member of the research-based industry trade associations BIOTECanada and Rx&D (now Innovative Medicines Canada), and was a member of the Board of Directors of ethicscentre.ca, the Canadian Centre for Ethics & Corporate Policy.
Karen holds a PhD in organometallic chemistry from McMaster University.